Preview

Clinical and experimental thyroidology

Advanced search

The change of character of a passing of a Grave’s disease in St. Petersburg from 1970 till 2010

https://doi.org/10.14341/ket20128259-63

Abstract

The first time the assessment of an iodine status of St. Petersburg was carried out in 1999 by the staff of faculty therapy of Saint-Petersburg State Medical University named after academician I.P Pavlov. The median urinary iodine concentration was 105 mkg/l. In 2010 the iodine status of St. Petersburg was carried out again: the median urinary iodine concentration was significantly higher – 148 mkg/l. In this regard it was reasonable to carry out comparison of indicators of a iodine status St. Petersburg and the features of a course of a Grave’s disease before the beginning of actions for elimination of iodine deficiency (till 1999) and during active of iodine prophylaxis. There were 310 patients with a Grave’s disease, they were diagnosed during the period from 1970 to 2010. From 1980 to 2010 the number of remissions of a disease gradually decreased: till 1990 the number of remissions was 21.7% whereas from2006 to 2011 the remissions were noted at 3.9% of patients with a diffuse toxic goiter. The group of patients with disease recurrence was separately analysed. Till 1990 among the patients with recurrence of a disease developed in 207.00 ± 35.18 months, in the group of the diseased in 1990–1995 – in 73.00 ± 13.95 months, in the group among the diseased in 1996–2000 – in 22.86 ± 3.46 months, in the group 2001–2005 – in 28.59 ± 5.19 month, and in 2006–2011 – in 7.75 ± 1.21 months.The carried-out research showed that for the last 20 years the essential change of character of a course of a Grave’s disease noted. It is possible to suppose that the revealed features, most likely are connected with the change of a iodine status of the region.

About the Authors

S Dora

kand. med. nauk, assistent kafedry fakul'tetskoy terapii Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta im. akad. I.P. Pavlova


E Krasilnikova

doktor med. nauk, professor kafedry fakul'tetskoy terapii Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta im. akad. I.P. Pavlova, vedushchiy nauchnyy sotrudnik FGU Federal'nyy tsentr serdtsa, krovi i endokrinologii im. V.A. Almazova


E Baranova

doktor med. nauk, professor kafedry fakul'tetskoy terapii Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta im. akad. I.P. Pavlova, vedushchiy nauchnyy sotrudnik FGU Federal'nyy tsentr serdtsa, krovi i endokrinologii im. V.A. Almazova


E Grigorieva

studentka VI kursa Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta im. akad. I.P. Pavlova


M Gudieva

ochnyy aspirant kafedry fakul'tetskoy khirurgii Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta im. akad. I.P. Pavlova


A Volkova

kand. med. nauk, dotsent kafedry fakul'tetskoy terapii Sankt-Peterburgskogo gosudarstvennogo meditsinskogo universiteta im. akad. I.P. Pavlova


References

1. Фадеев В.В. Заболевания щитовидной железы в регионе легкого йодного дефицита: эпидемиология, диагностика, лечение. М.: Видар-М, 2005.

2. Вандерпамп М. Эпидемиология нарушений функции щитовидной железы: гипо- и гипертиреоза. Интернет-журнал Тиронет, 2009; 2 (веб-сайт: http://thyronet.rusmedserv.com/spetsialistam/zhurnal/2009g/2/.

3. Kohrle J. et al. Flavonoids as a risk factor for goiter and hypothyroidism. Merck. Eur. Thyroid. Symposium, 2000. 41–53.

4. Lindsay R.H. et al. Antithyroid effects of coal-derived pollutants. J. Toxicol. Environ. Health. 1992; 37: 467–481.

5. Longer P. et al. Industrial pollution by polychlorinated biphenyls and the thyroid status of adult and adolescent populations. Merck Eur. Thyroid Symposium, 2000. 79–91.

6. Дедов И.И. Мельниченко Г.А., Фадеев В.В. Эндокринология. М., 2008.

7. Anthony P. Autoimmune Diseases in Endocrinology (Contemporary Endocrinology)/ P. Anthony – Weetman: Humana Press, 2008.

8. Handbook of Hyperthyroidism: Etiology, Diagnosis and Treatment (Endocrinology Research and Clinical Developments) / Eds.: L. Mertens, J. Bogaert. Nova Science Publishers Inc., 2010.

9. Harrison’s Endocrinology / Eds.: J. L. Jameson, D. L. Kasper, A.S. Fauci, E. Braunwald. McGraw-Hill Medical; Revised edition edition, 2006.

10. Дедов И.И., Мельниченко Г.А., Александрова Г.Ф. Диффузный токсический зоб. Клин. мед. 1992; 5: 65–70.

11. Петунина Н.А. Консервативное лечение диффузного токсического зоба: возможности, проблемы, пути решения. Эффектив. фармакотер. в эндокринол. 2009; 3: 14–20.

12. Zaletel K. et al. Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization. Croat. Med. J. 2011;52(5); 615–621.

13. Boukis M.A. et al. Thyroid hormone and immunological studies in endemic goiter. J. Clin. Endocrinol. Metab. 1983; 57: 859–862.

14. Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000; 160: 526–534.

15. Vanderpump M.P. et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. 1995; 43: 55–68.

16. Riccabona G. et al. Endemic goiter in Austria’s youth? Padiatr. Padol. 1981; 16 (2): 189–194.

17. Riccabona G. et al. Changes in thyroid surgery during iodine prophylaxis of endemic goiter. Wld. J. Surg. 1983; 7 (2): 195–200.

18. Vollenweider R. et al. Fokale Lymphozytare Thyreoiditis und Jodsalzprophylaxe. Vergleichende Untersuchungen an Strumaresektaten des Institutes fur Pathologie der Universitat Zurich. Schweiz Med. Wsehr. 1982; 112: 482–488.

19. Волкова А.Р. Йодoдефицит: миф и реальность. Врачебные ведомости 2002; 2: 50–53.

20. Дора С.В., Красильникова Е.И., Волкова А.Р. и др. Результаты эпидемиологического исследования по оценке йодного обеспечения Санкт-Петербурга. Клин. и эксперим. тиреоидол. 2011; 7 (3): 37–41.

21. The World Bank Group. Economics of Tobacco Control. Country data. [http://www1.worldbank.org/tobacco/brieflist_db.asp].

22. Lauberg L. et al. The Danish investigation of iodine intake and thyroid disease, DanThyr: status and perspectives. Eur. J. Endocrinol. 2006; 155 (2): 219–228.

23. Vestergaard P. et al. Smoking and thyroid disorders – a meta–analysis. Eur. J. Endocrinol. 2002; 146 (2): 153–161.

24. Фадеев В.В., Мельниченко Г.А. Болезнь Грейвса. Рус. мед. журн. 2002; 10 (27): 353.

25. Bartalena L. et al. Cigarette smoking and treatment outcomes in Graves’ ophthalmopathy. Ann. Intern. Med. 1988; 129 (2): 632–635.

26. Wiersinga W.M. et al. Epidemiology and prevention of Graves’ ophthalmopathy. Thyroid. 2002; 12 (10): 855–860.


Review

For citations:


 ,  ,  ,  ,  ,   The change of character of a passing of a Grave’s disease in St. Petersburg from 1970 till 2010. Clinical and experimental thyroidology. 2012;8(2):59-63. (In Russ.) https://doi.org/10.14341/ket20128259-63

Views: 520


ISSN 1995-5472 (Print)
ISSN 2310-3787 (Online)